Intellectual Property India Publishes Patent Application for Lysosomal Targeting Bifunctional Molecules For Degradation Of Thyroid Stimulating Hormone Receptor Autoantibodies

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647125652 A) filed by Lycia Therapeutics, Inc. on October 21, 2026, for Lysosomal Targeting Bifunctional Molecules For Degradation Of Thyroid Stimulating Hormone Receptor Autoantibodies.

Inventors include Lindhout, Darrin Anthony; and Shurtleff, Matthew.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present disclosure provides lysosomal targeting bifunctional molecules that target disease causing anti-TSHR autoantibodies for degradation. The lysosomal targeting bifunctional molecules include a ligand moiety that specifically binds to an asialoglycoprotein receptor (ASGPR), and which is lin...